Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3250-3259

  Singh, Christopher R ^a   Moulton, Rachel A ^a   Armitige, Lisa Y ^a   Bidani, Akhil ^b   Snuggs, Mark ^a   Dhandayuthapani, Subramanian ^c   Hunter, Robert L ^a   Jagannath, Chinnaswamy ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CATHEPSIN D; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM ANTIGEN 85B; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; EPITOPE MAPPING; HYBRIDOMA; IMMUNOFLUORESCENCE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 33747767882     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3250     Document Type: Article

References (61)

1. McMurray, D. N. 2000. Recent advances in improved tuberculosis vaccines. Indian J. Pediatr. 67: S58-S62.
2. Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 84: 93-101.
3. Russell, D. G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell. Biol. 2: 569-577.
4. Nakagawa, T. Y., and A. Y. Rudensky. 1999. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172: 121-129.
5. Medd, P. G., and B. M. Chain. 2000. Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation. Semin. Cell Dev. Biol. 11: 203-210.
6. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181: 257-270.
7. Clemens, D. L., B. Y. Lee, and M. A. Horwitz. 2002. The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm. Infect. Immun. 70: 5800-5807.
8. Vergne, I., J. Chua, S. B. Singh, and V. Deretic. 2004. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20: 367-394.
9. Hmama, Z., R. Gabathuler, W. A. Jefferies, G. de Jong, and N. E. Reiner. 1998. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161: 4882-4893.
10. Noss, E. H., C. V. Harding, and W. H. Boom. 2000. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201: 63-74.
11. Tobian, A. A., N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding. 2003. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J. Immunol. 171: 1413-1422.
12. Fulton, S. A., S. M. Reba, R. K. Pai, M. Pennini, M. Torres, C. V. Harding, and W. H. Boom. 2004. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect. Immun. 72: 2101-2110.
13. Ullrich, H. J., W. L. Beatty, and D. G. Russell. 1999. Direct delivery of pro-cathepsin D to phagosomes: implications for phagosome biogenesis and parasitism by Mycobacterium. Eur. J. Cell Biol. 78: 739-748.
14. Schaible, U. E., S. Sturgill-Koszycki, P. H. Schlesinger, and D. G. Russell. 1998. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160: 1290-1296.
15. Sturgill-Koszycki, S., U. E. Schaible, and D. G. Russell. 1996. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15: 6960-6968.
16. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263: 678-681.
17. Turk, V., B. Turk, G. Guncar, D. Turk, and J. Kos. 2002. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 42: 285-303.
18. Levine, T. P., and B. M. Chain. 1991. The cell biology of antigen processing. Crit. Rev. Biochem. Mol. Biol. 26: 439-473.
19. Sendide, K., A. E. Deghmane, D. Pechkovsky, Y. Av-Gay, A. Talal, and Z. Hmama. 2005. Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J. Immunol. 175: 5324-5332.
20. Ramachandra, L., E. Noss, W. H. Boom, and C. V. Harding. 2001. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J. Exp. Med. 194: 1421-1432.
21. Weinrich Olsen, A., L. A. van Pinxteren, L. Meng Okkels, P. Birk Rasmussen, and P. Andersen. 2001. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect. Immun. 69: 2773-2778.
22. Roche, P. W., K. D. Neupane, S. S. Failbus, A. Kamath, and W. J. Britton. 2001. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae. Int. J. Lepr. Other Mycobact. Dis. 69: 93-98.
23. Doherty, T. M., A. W. Olsen, J. Weischenfeldt, K. Huygen, S. D'Souza, T. K. Kondratieva, V. V. Yeremeev, A. S. Apt, B. Raupach, L. Grode, et al. 2004. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J. Infect. Dis. 190: 2146-2153.
24. Dhandayuthapani, S., L. E. Via, C. A. Thomas, P. M. Horowitz, D. Deretic, and V. Deretic. 1995. Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages. Mol. Microbiol. 17: 901-912.
25. Armitige, L. Y., C. Jagannath, A. R. Wanger, and S. J. Norris. 2000. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect. Immun. 68: 767-778.
26. Copenhaver, R. H., E. Sepulveda, L. Y. Armitige, J. K. Actor, A. Wanger, S. J. Norris, R. L. Hunter, and C. Jagannath. 2004. A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infect. Immun. 72: 7084-7095.
27. Rathman, M., M. D. Sjaastad, and S. Falkow. 1996. Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect. Immun. 64: 2765-2773.
28. Douglas, T., D. S. Daniel, B. K. Panda, C. Jagannath, and S. Dhandayuthapani. 2004. Methionine sulfoxide reductase A (MsrA) deficiency affects the survival of Mycobacterium smegmatis within macrophages. J. Bacteriol. 186: 3590-3598.
29. +-ATPase activity and expression in mouse bone marrow cultures. J. Bone Miner. Res. 14: 2127-2136.
30. Chen, C. S., W. N. Chen, M. Zhou, S. Arttamangkul, and R. P. Haugland. 2000. Probing the cathepsin D using a BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy. J. Biochem. Biophys. Methods 42: 137-151.
31. Ullrich, H. J., W. L. Beatty, and D. G. Russell. 2000. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J. Immunol. 165: 6073-6080.
32. Drowart, A., J. De Bruyn, K. Huygen, G. Damiani, H. P. Godfrey, M. Stelandre, J. C. Yernault, and J. P. van Vooren. 1992. Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex. Scand. J. Immunol. 36: 697-702.
33. +-ATPase in murine macrophages. J. Biol. Chem. 265: 21099-21107.
34. +" leak." J. Biol. Chem. 266: 24540-24548.
35. Via, L. E., R. A. Fratti, M. McFalone, E. Pagan-Ramos, D. Deretic, and V. Deretic. 1998. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111(Pt. 7): 897-905.
36. MacMicking, J. D., G. A. Taylor, and J. D. McKinney. 2003. Immune control of tuberculosis by IFN;-γ-inducible LRG-47. Science 302: 654-659.
37. Via, L. E., D. Deretic, R. J. Ulmer, N. S. Hibler, L. A. Huber, and V. Deretic. 1997. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by Rab5 and Rab7. J. Biol. Chem. 272: 13326-13331.
38. Gieselmann, V., A. Hasilik, and K. von Figura. 1985. Processing of human cathepsin D in lysosomes in vitro. J. Biol. Chem. 260: 3215-3220.
39. Gieselmann, V., R. Pohlmann, A. Hasilik, and K. von Figura. 1983. Biosynthesis and transport of cathepsin D in cultured human fibroblasts. J. Cell Biol. 97: 1-5.
40. van der Drift, A. C., J. M. van Noort, and J. Kruse. 1990. Catheptic processing of protein antigens: enzymic and molecular aspects. Semin. Immunol. 2: 255-271.
41. Baravalle, G., D. Schober, M. Huber, N. Bayer, R. F. Murphy, and R. Fuchs. 2005. Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature. Cell Tissue Res. 320: 99-113.
42. Hurtado-Lorenzo, A., M. Skinner, J. El Annan, M. Futai, G. H. Sun-Wada, S. Bourgoin, J. Casanova, A. Wildeman, S. Bechoua, D. A. Ausiello, et al. 2006. V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol. 8: 124-136.
43. McCoy, K. L., and R. H. Schwartz. 1988. The role of intracellular acidification in antigen processing. Immunol. Rev. 106: 129-147.
44. van Noort, J. M., S. M. Anderton, J. P. Wagenaar, M. H. Wauben, C. van Holten, and C. J. Boog. 1994. Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int. Immunol. 6: 603-609.
45. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167: 910-918.
46. Harth, G., B. Y. Lee, J. Wang, D. L. Clemens, and M. A. Horwitz. 1996. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64: 3038-3047.
47. Russell, D. G. 1998. What does 'inhibition of phagosome-lysosome fusion' really mean? Trends Microbiol. 6: 212-214.
48. Clemens, D. L., B. Y. Lee, and M. A. Horwitz. 2000. Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect. Immun. 68: 5154-5166.
49. Ferrari, G., H. Langen, M. Naito, and J. Pieters. 1999. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97: 435-447.
50. Vergne, I., J. Chua, H. H. Lee, M. Lucas, J. Belisle, and V. Deretic. 2005. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102: 4033-4038.
51. Vergne, I., R. A. Fratti, P. J. Hill, J. Chua, J. Belisle, and V. Deretic. 2004. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell 15: 751-760.
52. Schüller, S., J. Neefjes, T. Ottenhoff, J. Thole, and D. Young. 2001. Coronin is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in phagosome maintenance. Cell. Microbiol. 3: 785-793.
53. Beuzón, C. R., S. Méresse, K. E. Unsworth, J. Ruíz-Albert, S. Garvis, S. R. Waterman, T. A. Ryder, E. Boucrot, and D. W. Holden. 2000. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. EMBO J. 19: 3235-3249.
54. Gluck, S. L., R. D. Nelson, B. S. Lee, Z. Q. Wang, X. L. Guo, J. Y. Fu, and K. Zhang. 1992. Biochemistry of the renal V-ATPase. J. Exp. Biol. 172: 219-229.
55. Rook, G. A., K. Dheda, and A. Zumla. 2005. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5: 661-667.
56. Horwitz, M. A. 2005. Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect. 7: 947-954.
57. Horwitz, M. A., and G. Harth. 2003. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect. Immun. 71: 1672-1679.
58. Behr, M. A. 2002. BCG-different strains, different vaccines? Lancet Infect. Dis. 2: 86-92.
59. North, R. J., R. LaCourse, and L. Ryan. 1999. Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route. Infect. Immun. 67: 2010-2012.
60. Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslesa-Galic. 2000. Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97: 13853-13858.
61. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56: 648-661.